Structure Therapeutics Inc. American Depositary Shares (GPCR · NASDAQ)
GPCR · MARKET VIEW
Market view · as of Aug 3, 2026
Revenue (TTM)
$0
0.0% YoY
EPS (latest q)
$-0.35
vs $-0.33 est · miss
52-wk position
41.0%
-48.8% vs 52w high · -10.1% 1mo
Price (last ~year)
Structure Therapeutics Inc. (GPCR) is a clinical-stage biopharmaceutical company with a $3.41 billion market capitalization and no recorded revenue. As of March 31, 2026, the company held $316.2 million in cash against $5.8 million in total debt, while reporting a quarterly net loss of $76.2 million. Shares closed at $48.04, down 10.1% over the past month, with an analyst price target of $104.83.
Valuation
- Market cap
- $3.41B
- P/B
- 2.361
- EV/EBITDA
- -13.46
- Beta
- -1.569
- Analyst target
- $104.83
Quality & returns
- Operating margin
- 0.0%
- Profit margin
- 0.0%
- ROE
- -15.0%
- ROA
- -11.6%
Price movement
- Last
- $48.04
- 1-month
- -10.1%
- 3-month
- +16.9%
- RSI (14)
- 41
- vs SMA200
- -7.5%
- 52-wk position
- 41.0% -48.8% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $0 | $-89.6M | $-76.2M | $-74.8M |
| 2025-12-31 | $0 | $24.0M | $33.0M | $33.6M |
| 2025-09-30 | $0 | $-73.8M | $-65.7M | $-65.3M |
| 2025-06-30 | $0 | $-70.5M | $-61.7M | $-61.2M |
Recent news
- Somewhat-Bullish (GPCR) Price Dynamics and Execution-Aware Positioning · 2026-07-30
- Neutral Price to sales forward of Structure Therapeutics Inc. – NASDAQ:GPCR · 2026-07-29
- Neutral Structure Therapeutics Inc (GPCR) Balance Sheet · 2026-07-28
- Neutral Structure Therapeutics Inc (GPCR) Cash Flow · 2026-07-28
- Neutral Structure Therapeutics Inc (GPCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution · 2026-07-28
- Neutral Structure Therapeutics Inc. Revenue Breakdown – NASDAQ:GPCR · 2026-07-27
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)